{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T20:15:58Z","timestamp":1785615358361,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.jhep.2009.01.020","type":"journal-article","created":{"date-parts":[[2009,3,21]],"date-time":"2009-03-21T08:50:02Z","timestamp":1237625402000},"page":"1210-1218","source":"Crossref","is-referenced-by-count":130,"title":["Autoimmune hepatitis in Italy: The Bologna experience"],"prefix":"10.1016","volume":"50","author":[{"given":"Paolo","family":"Muratori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Granito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Quarneti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Menichella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco B.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2009.01.020_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.01.020_bib2","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1002\/hep.21059","article-title":"Autoimmune hepatitis, from mechanisms to therapy","volume":"43","author":"Manns","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1089-3261(02)00028-4","article-title":"Treatment strategies in autoimmune hepatitis","volume":"6","author":"Czaja","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.01.020_bib4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/gut.33.9.1260","article-title":"Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection","volume":"33","author":"Cassani","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.01.020_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jhep.2009.01.020_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","article-title":"Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.01.020_bib9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib10","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.01.020_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1749-6632.1965.tb19000.x","article-title":"Autoimmune hepatitis","volume":"124","author":"Mackay","year":"1965","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jhep.2009.01.020_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.01.020_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib16","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/0016-5085(93)90170-H","article-title":"How many types of autoimmune hepatitis are there?","volume":"105","author":"Maddrey","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.01.020_bib17","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","author":"Czaja","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib18","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2002.05921.x","article-title":"Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2036.2006.03013.x","article-title":"Clinical features of Japanese male patients with type 1 autoimmune hepatitis","volume":"24","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.01.020_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis","volume":"48","author":"Al-Chalabi","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.01.020_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2005.02403.x","article-title":"Diagnosis and treatment of autoimmune hepatitis at age 65 and older","volume":"21","author":"Verslype","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.01.020_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2005.02488.x","article-title":"Clinical features of type 1 autoimmune hepatitis in elderly Italian patients","volume":"21","author":"Granito","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.01.020_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.hepres.2006.06.007","article-title":"Clinical characteristics of autoimmune hepatitis in older aged patients","volume":"36","author":"Miyake","year":"2006","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2009.01.020_bib24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2006.03104.x","article-title":"Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study","volume":"24","author":"Floreani","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.01.020_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.01.020_bib26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jhep.2005.06.006","article-title":"Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis","volume":"43","author":"Miyake","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.01.020_bib27","doi-asserted-by":"crossref","first-page":"S630","DOI":"10.1111\/j.1572-0241.2006.00979.x","article-title":"Treatment strategies for autoimmune hepatitis","volume":"101","author":"Heathcote","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1572-0241.2007.01147.x","article-title":"Remission in autoimmune hepatitis: what is it, and can it ever be achieved?","volume":"102","author":"Al-Chalabi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen\u2013antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.01.020_bib32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.01.020_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.37.3.406","article-title":"Heterogeneity of liver\/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease","volume":"37","author":"Muratori","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.01.020_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hch072","article-title":"Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the \u2019acute\u2019 type","volume":"97","author":"Ferrari","year":"2004","journal-title":"Qjm"},{"key":"10.1016\/j.jhep.2009.01.020_bib36","first-page":"2197","article-title":"Genetic distinctions between types 1 and 2 autoimmune hepatitis","volume":"92","author":"Czaja","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib37","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","article-title":"Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2","volume":"94","author":"Bittencourt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(02)80564-5","article-title":"Different immunogenetic background in autoimmune hepatitis type 1, type 2 and autoimmune sclerosing cholangitis","volume":"36","author":"Underhill","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.01.020_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib40","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1111\/j.1572-0241.2000.03207.x","article-title":"LKM-positive autoimmune hepatitis in the western United States: a case series","volume":"95","author":"Duchini","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib41","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.01.020_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib43","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.01.020_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2005.11.050","article-title":"In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases?","volume":"44","author":"Verma","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.01.020_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1478-3231.2007.01444.x","article-title":"Consequences of treatment withdrawal in type 1 autoimmune hepatitis","volume":"27","author":"Montano-Loza","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.01.020_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.20539","article-title":"Treatment challenges and investigational opportunities in autoimmune hepatitis","volume":"41","author":"Czaja","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.01.020_bib47","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:25:08Z","timestamp":1545351908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827809001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0168827809001585"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2009.01.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}